HDRN (OTC BB 1.75) ...this is from July post ebd of qtr results also below...about 6.5m shares outstanding...there were add'l contracts of several million before this announcment and there will be in my opinion a huge emphasis here in the future...I would note that this is one of the very very few pure plays here..in addition, HDRN has significant staffing contracts w/the dod and defense agencies.
(COMTEX) B: HADRON INC - Subsidiary Awarded New $3.6 Million Biodefense
B: HADRON INC - Subsidiary Awarded New $3.6 Million Biodefense Contract By
DARPA
New York, New York, Jul 09, 2001 (Market News Publishing via COMTEX) -- Hadron,
Inc. announced that its Advanced Biosystems, Inc. subsidiary has been awarded a
new $3.6 million contract by the Defense Advanced Research Projects Agency
(DARPA). This eighteen-month contract represents a continuation of medical
biodefense research previously funded by DARPA.
Specifically, this contract funds research into ways to enhance the body's
innate immune response against a wide variety of biological weapons threats.
The areas under investigation will include both in vitro and in vivo
investigation of the effects of certain cytokine combinations, other natural and
synthetic modulators of the innate immune response, computer modeling of
cytokines and cytokine-receptors, and the construction of new peptides which
mimic the effects of certain cytokines. The research is being conducted under
the direction of Advanced Biosystems' President, Dr. Ken Alibek, who has been
developing these and other novel approaches to the development of new
prophylactic means and treatments for a broad spectrum of infectious diseases.
Dr. Alibek stated, "We are gratified by our preliminary research results to
date, and are pleased to continue working with DARPA to advance this research
into new medical concepts regarding protection against biological threat
agents." Hadron's President and Chief Executive Officer, Sterling Phillips,
commented, "We continue to have great confidence in Advanced Biosystems'
multi-phase programs to develop defenses against, and treatments for, biological
agents that may be used in warfare or terrorist attacks. Since support of
national security is the key focus of Hadron, we are pleased these programs are
part of our Company."
Hadron specializes in developing leading edge intelligence and biodefense
solutions in support of our nation's security. Hadron focuses on developing
innovative technical solutions for the intelligence community, analyzing and
supporting defense systems and developing medical defenses and treatments for
toxic agents used in biological warfare and terrorism. The Company's stock
trades on the OTC Electronic Bulletin Board under the symbol HDRN. Hadron can be
found on the Internet at hadron.com . Hadron investor relations can
be contacted at 703-329-9400 or via email at agordon@hadron.com .
Except for the historical information contained herein, this press release
contains forward-looking statements within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended, that involve a number of risks
and uncertainties. These forward-looking statements may be identified by
reference to a future period by use of forward-looking terminology such as
"anticipate," "expect," "could," "intend," "may" and other words of similar
nature. There are certain important factors and risks that could cause results
to differ materially from those anticipated by the statements contained herein.
Such factors and risks include business conditions and growth in the information
services, engineering services, software development and government contracting
arenas and in the economy in general. Competitive factors include the pressures
toward consolidation of small government contracts into larger contracts awarded
to major, multi-national corporations; and the Company's ability to continue to
recruit and retain highly skilled technical, managerial and sales/marketing
personnel. Other risks may be detailed from time to time in the Company's
filings with the Securities and Exchange Commission. Hadron undertakes no
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041.
(C) 2001 Market News Publishing Inc.
-0-
KEYWORD: New York, New York
*** end of story ***
(COMTEX) B: HADRON INC - 2nd Quarter and Year-to-Date Earnings
B: HADRON INC - 2nd Quarter and Year-to-Date Earnings
New York, New York, Aug 02, 2001 (Market News Publishing via COMTEX) -- Hadron,
Inc. announced financial results for the first half and second quarter of fiscal
2001, ended June 30, 2001. For the six months ended June 30, 2001, Hadron
recorded operating income of $190,200 compared to $60,300 and net income of
$93,700 versus a net loss of $113,800 for the comparable six months of the
previous year. For the second quarter, the Company reported operating income of
$106,500 and net income of $72,400 ($0.01 net income per share) compared to
operating income of $261,900 and net income of $203,900 ($0.03 net income per
share) for the comparable quarter of fiscal 2000. Hadron's earnings before
interest, taxes, depreciation and amortization (EBITDA) for the second quarter
were $225,000; and for the six months ended June 30, 2001, EBITDA was $403,000.
Hadron reported revenues of $4.4 million for the second quarter of fiscal 2001
compared to revenues of $4.9 million for the prior year quarter, and revenues of
$8.6 million for the six months ended June 30, 2001 versus revenues of $9.6
million for the comparable six month period of the prior fiscal year.
"The first six months of the current fiscal year, compared to last year, show
marked financial improvement for Hadron," said Sterling Phillips, Hadron's
President and Chief Executive Officer. "The Company continues to show profitable
results in the second quarter. The decrease in the Company's profitability
compared to the same period last year is primarily due to increased investments
in new business initiatives and certain customers' budget reductions, which have
resulted from changes in Department of Defense allocations. These reductions
have been partially offset by increased profits in the Company's biowarfare
defense programs," he continued.
Hadron specializes in developing intelligence and biodefense solutions in
support of our Nation's security. Hadron focuses on developing innovative
technical solutions for the intelligence community, analyzing and supporting
defense systems and developing medical defenses and treatments for toxic agents
used in biological warfare and terrorism. The Company's stock trades on the OTC
Electronic Bulletin Board under the symbol HDRN. Hadron can be found on the
Internet at hadron.com . Hadron investor relations can be contacted
at (703) 329-9400 or via email at agordon@hadron.com .
Hadron, Inc.
Selected Financial Data
(unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
2001 2000 2001 2000
Revenues $4,357,900 $4,879,200 $8,587,500 $9,634,000
Operating Income 106,500 261,900 190,200 60,300
Net Income (Loss) 72,400 203,900 93,700 (113,800)
Net Income (Loss) Per Share:
Basic $0.01 $0.04 $0.01 $(0.03)
Diluted $0.01 $0.03 $0.01 $(0.03)
Weighted avg. # shares:
Basic 6,517,780 5,100,172 6,511,787 3,953,612
Diluted 7,985,845 6,648,677 7,882,512 3,953,612
June 30, 2001 Dec. 31, 2000
(unaudited)
Total Shareholders'
Equity $2,166,300 $2,001,900
Except for the historical information contained herein, this press release
contains forward-looking statements within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended, that involve a number of risks
and uncertainties. These forward-looking statements may be identified by
reference to a future period by use of forward-looking terminology such as
"anticipate," "expect," "could," "intend," "may" and other words of a similar
nature. There are certain important factors and risks that could cause results
to differ materially from those anticipated by the statements contained herein.
Such factors and risks include business conditions and growth in the information
services, engineering services, software development and government contracting
arenas and in the economy in general. Competitive factors include the pressures
toward consolidation of small government contracts into larger contracts awarded
to major, multi-national corporations; and the Company's ability to continue to
recruit and retain highly skilled technical, managerial and sales/marketing
personnel. Other risks may be detailed from time to time in the Company's
filings with the Securities and Exchange Commission. Hadron undertakes no
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041.
(C) 2001 Market News Publishing Inc.
-0-
KEYWORD: New York, New York
*** end of story *** |
